OUR SENIOR STAFF
Dr. John Naleway
President, CEO of MGTI - Ph.D. Biochemistry, Adjunct faculty member in the Departments of Chemistry and Molecular Biology at the University of Oregon.
jnaleway@markergene.com
Timothy L. McCutcheon
Legal Counsel - MS Biology, J.D., University of Oregon, corporate and patent attorney with extensive science background.
mccutcheonlaw@juno.com
Michael P. Coughlin
Director of Business Development - MBA University of Oregon Business School, Sr. Partner in AmEuro, LLC and former CEO of Percon, Inc.
mpcoughlin@msn.com
Thomas A. Lyons
Head, Cell Biology Group - BS Biology, University of Oregon.
tlyons@markergene.com
Ryan M. Link-Cole
Head of Chemistry - MS Organic Chemistry, Oregon State University
rlinkcole@markergene.com
Alisa A. Naleway
Director of Operations - MS Organic Chemistry, University of Alberta-Edmonton
analeway@markergene.com
Marker Gene Technologies, Inc. was founded in 1993 at the University of Oregon Riverfront Research Park to develop new products for the biotechnology and medical industries. The company has received a number of competitive grant awards for its work in cancer research and therapeutics from the National Institutes of Health as well as funding from the National Science Foundation for new uses of Marker Genes for agricultural biotechnology, cell culturing, bacteriology and basic research applications. Contact us for more information about our work in these areas.
The company has a staff of highly trained professionals with expertise in the areas of carbohydrate chemistry and biology; organic synthesis; fluorescence chemistry; molecular biology; DNA sequencing; subcloning; Northern blotting; Western blotting; cell culture; gel electrophoresis of DNA, RNA, and proteins; cell viability assays; bacterial detection; and related areas.
OUR DISTRIBUTORS:
Copyright Warranty
|
